Skip to Content

ME-344 Approval Status

FDA Approved: No
Brand name: ME-344
Company: MEI Pharma, Inc.
Treatment for: Ovarian Cancer, Small Cell Lung Cancer

ME-344 is a novel mitochondrial inhibitor in development for the treatment of ovarian cancer and small cell lung cancer.

Development Status and FDA Approval Process for ME-344

DateArticle
Mar  8, 2012Marshall Edwards Submits Investigational New Drug Application for Oncology Drug Candidate ME-344

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide